All Stories

  1. A drug safety evaluation of abiraterone acetate in the treatment of prostate cancer

    Article • Expert Opinion on Drug Safety, August 2019, Taylor & Francis

    Michele Marchioni, Luca Cindolo

  2. Abiraterone acetate for early stage metastatic prostate cancer: patient selection and special considerations

    Article • Therapeutics and Clinical Risk Management, December 2018, Dove Medical Press

    Luca Cindolo

  3. Abiraterone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: a systematic review of ‘real-life’ studies

    Article • Therapeutic Advances in Urology, July 2018, SAGE Publications

    Luca Cindolo

  4. Survival benefit of local versus no local treatment for metastatic prostate cancer-Impact of baseline PSA and metastatic substages

    Article • The Prostate, April 2018, Wiley

    Luca Cindolo, Michele Marchioni

  5. The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT2-3 non-metastatic renal cell carcinoma treated with radical nephrectomy

    Article • BJU International, October 2017, Wiley

    Luca Cindolo, Michele Marchioni, Marco Bandini

  6. MP50-11 THE SURGICAL EXPERIENCE INFLUENCES THE SAFETY BUT NOT EFFICACY OF RIRS FOR KIDNEY STONES: A PROPENSITY SCORE ANALYSIS

    Article • The Journal of Urology, April 2017, Elsevier

    Luca Cindolo

  7. MP49-02 PERIOPERATIVE MORBIDITY OF CLAMP VS OFF-CLAMP ROBOTIC PARTIAL NEPHRECTOMY: PRELIMINARY RESULTS FROM A MULTICENTRE RANDOMIZED CLINICAL TRIAL (THE CLOCK STUDY)

    Article • The Journal of Urology, April 2017, Elsevier

    Luca Cindolo

  8. PD49-06 THE ADHERENCE TO THE EAU GUIDELINES ON PENILE CANCER TREATMENT COULD INFLUENCE THE SURVIVAL: MULTICENTER, RETROSPECTIVE, EUROPEAN STUDY.

    Article • The Journal of Urology, April 2017, Elsevier

    Luca Cindolo

  9. “Hair in the Bladder”: An Unusual Finding

    Article • Journal of Endourology Case Reports, March 2017, Mary Ann Liebert Inc

    Luca Cindolo

  10. Vaporize, anatomically vaporize or enucleate the prostate? The flexible use of the GreenLight laser

    Article • International Urology and Nephrology, January 2017, Springer Science + Business Media

    Luca Cindolo

  11. High Neutrophil-to-lymphocyte Ratio as Prognostic Factor in Patients Affected by Upper Tract Urothelial Cancer: A Systematic Review and Meta-analysis

    Article • Clinical Genitourinary Cancer, December 2016, Elsevier

    Luca Cindolo

  12. Infective complications after retrograde intrarenal surgery: a new standardized classification system

    Article • International Urology and Nephrology, July 2016, Springer Science + Business Media

    Luca Cindolo

  13. A prospective multicenter European study on flexible ureterorenoscopy for the management of renal stone

    Article • June 2016, FapUNIFESP (SciELO)

    Luca Cindolo

  14. Evaluation of clinical benefits of abiraterone acetate in "real life" study

    Article • May 2016, Springer Science + Business Media

    Luca Cindolo

  15. A fatal mycotic sepsis after retrograde intrarenal surgery: a case report and literature review

    Article • Urologia Journal, May 2016, SAGE Publications

    Luca Cindolo

  16. Intraoperative presentation of Bochdalek’s hernia in an adult during robotic-assisted partial nephrectomy: An uncommon situation and literature review

    Article • Archivio Italiano di Urologia e Andrologia, January 2016, PAGEPress Publications

    Luca Cindolo

  17. Work up of incidental adrenal mass: state of the art

    Article • Urologia Journal, January 2016, SAGE Publications

    Luca Cindolo, Work up of incidental adrenal mass: state of art Maida MB Bada

  18. Features, risk factors and clinical outcome of “very late” recurrences after surgery for localized renal carcinoma: A retrospective evaluation of a cohort with a minimum of 10 years of follow up

    Article • International Journal of Urology, November 2015, Wiley

    Luca Cindolo

  19. Open Versus Laparoscopic Adrenalectomy for Adrenocortical Carcinoma: A Meta-analysis of Surgical and Oncological Outcomes

    Article • Annals of Surgical Oncology, October 2015, Springer Science + Business Media

    Luca Cindolo

  20. Current Pharmacological Treatment for Male LUTS due to BPH: Dutasteride or Finasteride?

    Article • Current Drug Targets, October 2015, Bentham Science Publishers

    Luca Cindolo

  21. The Current Indications and the Benefits of Combining a β3-Agonist with an Anticholinergic for the Treatment of OAB

    Article • Current Drug Targets, October 2015, Bentham Science Publishers

    Luca Cindolo

  22. Patient’s adherence on pharmacological therapy for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS) is different: is combination therapy better than monotherapy?

    Article • BMC Urology, September 2015, Springer Science + Business Media

    Luca Cindolo

  23. Drug Adherence and Clinical Outcomes for Patients Under Pharmacological Therapy for Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia: Population-based Cohort Study

    Article • European Urology, September 2015, Elsevier

    Luca Cindolo

  24. Mortality and flexible ureteroscopy: analysis of six cases

    Article • World Journal of Urology, July 2015, Springer Science + Business Media

    Luca Cindolo

  25. Giant renal artery aneurysm: A case report

    Article • Archivio Italiano di Urologia e Andrologia, July 2015, PAGEPress Publications

    Luca Cindolo

  26. Physical activity as a risk factor for prostate cancer diagnosis: a prospective biopsy cohort analysis

    Article • BJU International, June 2015, Wiley

    Luca Cindolo

  27. Prognostic significance of perirenal fat invasion and tumor size in pT1 to pT3a renal cell carcinoma: Results of a comprehensive multicenter study of the CORONA project—Can we improve prognostic discrimination of patients with stage pT3a tumors?

    Article • Journal of Clinical Oncology, March 2015, American Society of Clinical Oncology (ASCO)

    Luca Cindolo

  28. Safety, efficacy and reliability of 180-W GreenLight laser technology for prostate vaporization: review of the literature

    Article • World Journal of Urology, February 2015, Springer Science + Business Media

    Luca Cindolo

  29. Editorial Comment to Nomograms incorporating serum C-reactive protein effectively predict mortality before and after surgical treatment of renal cell carcinoma

    Article • International Journal of Urology, January 2015, Wiley

    Luca Cindolo

  30. Metabolic Syndrome and Lower Urinary Tract Symptoms in Patients With Benign Prostatic Enlargement: A Possible Link to Storage Symptoms

    Article • Urology, November 2014, Elsevier

    Luca Cindolo

  31. Results of a comparative study analyzing octogenarians with renal cell carcinoma in a competing risk analysis with patients in the seventh decade of life1Matthias May and Luca Cindolo have equally contributed to first authorship.2Sabine Brookman-May an...

    Article • Urologic Oncology Seminars and Original Investigations, November 2014, Elsevier

    Luca Cindolo

  32. The R.E.N.A.L. Nephrometric Nomogram Cannot Accurately Predict Malignancy or Aggressiveness of Small Renal Masses Amenable to Partial Nephrectomy

    Article • Clinical Genitourinary Cancer, October 2014, Elsevier

    Luca Cindolo

  33. Sky is no limit for ureteroscopy: extending the indications and special circumstances

    Article • World Journal of Urology, June 2014, Springer Science + Business Media

    Luca Cindolo

  34. Efficacy and safety of dutasteride for the treatment of symptomatic benign prostatic hyperplasia (BPH): a systematic review and meta-analysis

    Article • World Journal of Urology, April 2014, Springer Science + Business Media

    Luca Cindolo

  35. Clinical effects and economical impact of dutasteride and finasteride therapy in Italian men with LUTS

    Article • Archivio Italiano di Urologia e Andrologia, December 2013, PAGEPress Publications

    Luca Cindolo

  36. Prognostic Effect of Sarcomatoid Dedifferentiation in Patients With Surgically Treated Renal Cell Carcinoma: A Matched-Pair Analysis

    Article • Clinical Genitourinary Cancer, December 2013, Elsevier

    Luca Cindolo

  37. Is Computed Tomography Mandatory for the Detection of Residual Stone Fragments After Percutaneous Nephrolithotomy?

    Article • Journal of Endourology, November 2013, Mary Ann Liebert Inc

    Luca Cindolo

  38. Actual medical management of lower urinary tract symptoms related to benign prostatic hyperplasia: temporal trends of prescription and hospitalization rates over 5 years in a large population of Italian men

    Article • International Urology and Nephrology, October 2013, Springer Science + Business Media

    Luca Cindolo

  39. Abdominal obesity as risk factor for prostate cancer diagnosis and high grade disease: A prospective multicenter Italian cohort study

    Article • Urologic Oncology Seminars and Original Investigations, October 2013, Elsevier

    Luca Cindolo

  40. Laparoendoscopic Single-site Partial Nephrectomy: A Multi-institutional Outcome Analysis

    Article • European Urology, August 2013, Elsevier

    Luca Cindolo

  41. Contemporary monopolar and bipolar transurethral resection of the prostate: prospective assessment of complications using the Clavien system

    Article • International Urology and Nephrology, May 2013, Springer Science + Business Media

    Luca Cindolo

  42. 1074 IMPACT OF CLINICAL AND HISTOPATHOLOGICAL PARAMETERS ON DISEASE-SPECIFIC SURVIVAL IN PATIENTS WITH COLLECTING DUCT RENAL CELL CARCINOMA

    Article • The Journal of Urology, April 2013, Wolters Kluwer Health

    Giacomo Novara, Luca Cindolo

  43. 741 TIME TO RECURRENCE IS A SIGNIFICANT PREDICTOR OF CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH RECURRENT RENAL CELL CARCINOMA - RESULTS FROM A COMPREHENSIVE MULTI-CENTER DATABASE (CORONA/SATURN-PROJECT)

    Article • The Journal of Urology, April 2013, Wolters Kluwer Health

    Giacomo Novara, Luca Cindolo

  44. 742 FEATURES ASSOCIATED WITH RECURRENCE BEYOND 5 YEARS AFTER NEPHRECTOMY AND NEPHRON-SPARING SURGERY FOR RENAL CELL CARCINOMA: DEVELOPMENT AND INTERNAL VALIDATION OF A RISK-MODEL TO PREDICT LATE RECURRENCE BASED ON A LARGE MULTI-CENTER DATABASE (CORONA...

    Article • The Journal of Urology, April 2013, Wolters Kluwer Health

    Giacomo Novara, Luca Cindolo

  45. 844 PREDICTIVE FACTORS OF FAVORABLE OUTCOME IN LAPAROENDOSCOPIC SINGLE-SITE (LESS) PARTIAL NEPHRECTOMY: A LARGE MULTI-INSTITUTIONAL ANALYSIS

    Article • The Journal of Urology, April 2013, Elsevier

    Luca Cindolo

  46. Laparoendoscopic Single-site Partial Nephrectomy Without Ischemia for Very Small, Exophytic Renal Masses: Surgical Details and Functional Outcomes

    Article • European Urology, April 2013, Elsevier

    Luca Cindolo

  47. The effects of dutasteride and finasteride on BPH-related hospitalization, surgery and prostate cancer diagnosis: a record-linkage analysis

    Article • World Journal of Urology, December 2012, Springer Science + Business Media

    Luca Cindolo

  48. A comparison of hexaminolevulinate (Hexvix®) fluorescence cystoscopy and white-light cystoscopy for detection of bladder cancer: results of the HeRo observational study

    Article • Surgical Endoscopy, June 2012, Springer Science + Business Media

    Luca Cindolo

  49. Mini‐laparoscopy, laparoendoscopic single‐site surgery and natural orifice transluminal endoscopic surgery‐assisted laparoscopy: novice surgeons' performance and perception in a porcine nephrectomy model

    Article • BJU International, June 2012, Wiley

    Luca Cindolo

  50. 2023 LONGER OPERATIVE TIME IS ASSOCIATED WITH POST-OPERATIVE TURP COMPLICATIONS A MODIFIED CLAVIEN CLASSIFICATION SYSTEM ANALYSIS

    Article • The Journal of Urology, April 2012, Elsevier

    Luca Cindolo

  51. 1765 OPERATIVE TIME IS ASSOCIATED WITH POST-OPERATIVE TURB COMPLICATIONS: A MODIFIED CLAVIEN CLASSIFICATION SYSTEM ANALYSIS

    Article • The Journal of Urology, April 2012, Elsevier

    Luca Cindolo

  52. Reply from Authors re: Jonathan A. Coleman. Laparoendoscopic Single-Site Surgery for the Upper Urinary Tract: Awaiting Evidence. Eur Urol 2012;61:517–8

    Article • European Urology, March 2012, Elsevier

    Luca Cindolo

  53. Laparoendoscopic Single-Site Upper Urinary Tract Surgery: Assessment of Postoperative Complications and Analysis of Risk Factors

    Article • European Urology, March 2012, Elsevier

    Luca Cindolo

  54. Atypical presentations and rare metastatic sites of renal cell carcinoma: a review of case reports

    Article • Journal of Medical Case Reports, September 2011, Springer Science + Business Media

    Luca Cindolo

  55. Laparoendoscopic Single-Site Unclamped Nephron-Sparing Surgery: A Case Report

    Article • European Urology, September 2011, Elsevier

    Luca Cindolo

  56. The influence of ejaculation and abstinence on urinary flow rates

    Article • Neurourology and Urodynamics, July 2011, Wiley

    Luca Cindolo

  57. Expression of lumbosacral HOX genes, crucial in kidney organogenesis, is systematically deregulated in clear cell kidney cancers

    Article • Anti-Cancer Drugs, June 2011, Wolters Kluwer Health

    Dr alfredo procino, Luca Cindolo, GAETANO FACCHINI

  58. Laparoendoscopic single site (LESS) adrenalectomy: Technique and outcomes

    Article • World Journal of Urology, April 2011, Springer Science + Business Media

    Luca Cindolo

  59. 280 UNCLAMP LESS PARTIAL NEPHRECTOMY

    Article • European Urology Supplements, March 2011, Elsevier

    Luca Cindolo

  60. Laparoendoscopic Single-Site Partial Nephrectomy Without Ischemia

    Article • Journal of Endourology, December 2010, Mary Ann Liebert Inc

    Luca Cindolo

  61. Differential role of CD133 and CXCR4 in renal cell carcinoma

    Article • Cell Cycle, November 2010, Taylor & Francis

    Luca Cindolo

  62. Assessing Feasibility and Safety of Laparoendoscopic Single-Site Surgery Adrenalectomy: Initial Experience

    Article • Journal of Endourology, June 2010, Mary Ann Liebert Inc

    Luca Cindolo

  63. Limited Prognostic Value of Tumor Necrosis in Patients With Renal Cell Carcinoma

    Article • Urology, June 2010, Elsevier

    Luca Cindolo

  64. Re: Luca Cindolo, Stefano Gidaro, Fabiola R. Tamburro, Luigi Schips. Laparo-Endoscopic Single-Site Left Transperitoneal Adrenalectomy. Eur Urol 2010;57:911–4

    Article • European Urology, May 2010, Elsevier

    Luca Cindolo

  65. Laparo-Endoscopic Single-Site Left Transperitoneal Adrenalectomy

    Article • European Urology, May 2010, Elsevier

    Luca Cindolo

  66. V8 LESS ADRENALECTOMY

    Article • European Urology Supplements, April 2010, Elsevier

    Luca Cindolo

  67. V6 LEFT LESS PARTIAL NEPHRECTOMY WITHOUT ISCHEMIA: FIRST EXPERIENCE

    Article • European Urology Supplements, April 2010, Elsevier

    Luca Cindolo

  68. Survival of patients with nonmetastatic pT3 renal tumours: a matched comparison of laparoscopic vs open radical nephrectomy

    Article • BJU International, December 2009, Wiley

    Luca Cindolo

  69. Conditional Survival Predictions After Nephrectomy for Renal Cell Carcinoma

    Article • The Journal of Urology, December 2009, Elsevier

    Luca Cindolo

  70. Can Renal Mass Biopsy Assessment of Tumor Grade be Safely Substituted for by a Predictive Model?

    Article • The Journal of Urology, December 2009, Elsevier

    Luca Cindolo

  71. LOOKING AT THE PROSTATES OF PATIENTS WITH BLADDER CANCER: A THOUGHTFUL EXERCISE

    Article • BJU International, July 2009, Wiley

    Luca Cindolo

  72. Urological applications of N.O.T.E.S.

    Article • Surgical Oncology, June 2009, Elsevier

    Luca Cindolo

  73. Partial Versus Radical Nephrectomy in Patients With Adverse Clinical or Pathologic Characteristics

    Article • Urology, June 2009, Elsevier

    Luca Cindolo

  74. Editorial Comment on: Metastin Inhibits Migration and Invasion of Renal Cell Carcinoma with Overexpression of Metastin Receptor

    Article • European Urology, February 2009, Elsevier

    Luca Cindolo

  75. A Preoperative Prognostic Model for Patients Treated with Nephrectomy for Renal Cell Carcinoma

    Article • European Urology, February 2009, Elsevier

    Luca Cindolo

  76. Prognostic Value of Renal Vein and Inferior Vena Cava Involvement in Renal Cell Carcinoma

    Article • European Urology, February 2009, Elsevier

    Luca Cindolo

  77. Thromboprophylaxis in Radical Retropubic Prostatectomy: Efficacy and Patient Compliance of a Dual Modality

    Article • Urologia Internationalis, January 2009, Karger Publishers

    Luca Cindolo

  78. Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma

    Article • BJU International, January 2009, Wiley

    Luca Cindolo

  79. Age at diagnosis is a determinant factor of renal cell carcinoma– specific survival in patients treated with nephrectomy

    Article • Canadian Urological Association Journal, December 2008, Canadian Urological Association Journal

    Luca Cindolo

  80. Prognostic variables to predict cancer-related death in incidental renal tumours

    Article • BJU International, September 2008, Wiley

    Luca Cindolo

  81. Validation by calibration of the UCLA integrated staging system prognostic model for nonmetastatic renal cell carcinoma after nephrectomy

    Article • Cancer, July 2008, Wiley

    Luca Cindolo

  82. Neuroendocrine Differentiation in Prostate Cancer: From Lab to Bedside

    Article • Urologia Internationalis, November 2007, Karger Publishers

    Luca Cindolo

  83. NeuroD1 Expression in Human Prostate Cancer: Can It Contribute to Neuroendocrine Differentiation Comprehension?

    Article • European Urology, November 2007, Elsevier

    Luca Cindolo

  84. Collecting Duct Renal Cell Carcinoma: A Matched Analysis of 41 Cases

    Article • European Urology, October 2007, Elsevier

    Giacomo Novara, Luca Cindolo

  85. Patients with distant metastases from renal cell carcinoma can be accurately identified: external validation of a new nomogram

    Article • BJU International, October 2007, Wiley

    Luca Cindolo

  86. A New Staging System for Locally Advanced (pT3–4) Renal Cell Carcinoma: A Multicenter European Study Including 2,000 Patients

    Article • The Journal of Urology, August 2007, Wolters Kluwer Health

    Giacomo Novara, Luca Cindolo

  87. Prognostic Relevance of Tumour Size in T3a Renal Cell Carcinoma: A Multicentre Experience

    Article • European Urology, July 2007, Elsevier

    Luca Cindolo

  88. Renal Cell Carcinoma with Nodal Metastases in the Absence of Distant Metastatic Disease: Prognostic Indicators of Disease-Specific Survival

    Article • European Urology, June 2007, Elsevier

    Luca Cindolo

  89. Relationship between Age at Diagnosis and Clinicopathologic Features of Renal Cell Carcinoma

    Article • European Urology, May 2007, Elsevier

    Luca Cindolo

  90. Multi-Institutional Validation of a New Renal Cancer–Specific Survival Nomogram

    Article • Journal of Clinical Oncology, April 2007, American Society of Clinical Oncology (ASCO)

    Luca Cindolo

  91. ECOG performance status 0 or 1 and symptom classification do not improve the ability to predict renal cell carcinoma-specific survival

    Article • European Journal of Cancer, April 2007, Elsevier

    Luca Cindolo

  92. Prognostic ability of simplified nuclear grading of renal cell carcinoma

    Article • Cancer, January 2007, Wiley

    Luca Cindolo

  93. Patients with renal cell carcinoma nodal metastases can be accurately identified: External validation of a new nomogram

    Article • International Journal of Cancer, January 2007, Wiley

    Luca Cindolo

  94. Tumor Size Improves the Accuracy of TNM Predictions in Patients with Renal Cancer

    Article • European Urology, September 2006, Elsevier

    Luca Cindolo

  95. HOW TO DECREASE PAIN DURING TRANSRECTAL ULTRASOUND GUIDED PROSTATE BIOPSY: A LOOK AT THE LITERATURE

    Article • The Journal of Urology, December 2005, Elsevier

    Luca Cindolo

  96. Proposal for revision of the TNM classification system for renal cell carcinoma

    Article • Cancer, October 2005, Wiley

    Giacomo Novara, Luca Cindolo

  97. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy

    Article • Cancer, October 2005, Wiley

    Luca Cindolo

  98. Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma

    Article • Cancer, July 2005, Wiley

    Giacomo Novara, Luca Cindolo

  99. Prognostic Value of Histologic Subtypes in Renal Cell Carcinoma: A Multicenter Experience

    Article • Journal of Clinical Oncology, April 2005, American Society of Clinical Oncology (ASCO)

    Luca Cindolo

  100. Chromophobe renal cell carcinoma: Comprehensive analysis of 104 cases from multicenter European database

    Article • Urology, April 2005, Elsevier

    Luca Cindolo

  101. MULTI-INSTITUTIONAL VALIDATION OF A SYMPTOM BASED CLASSIFICATION FOR RENAL CELL CARCINOMA

    Article • The Journal of Urology, September 2004, Elsevier

    Luca Cindolo

  102. SAFETY AND EFFICACY OF PARTIAL NEPHRECTOMY FOR ALL T1 TUMORS BASED ON AN INTERNATIONAL MULTICENTER EXPERIENCE

    Article • The Journal of Urology, June 2004, Elsevier

    Luca Cindolo

  103. Standard versus Hydrophilic Catheterization in the Adjuvant Treatment of Patients with Superficial Bladder Cancer

    Article • Urologia Internationalis, January 2004, Karger Publishers

    Luca Cindolo

  104. Hyperexpression of locus C genes in the HOX network is strongly associated in vivo with human bladder transitional cell carcinomas

    Article • Oncogene, September 2003, Nature

    Luca Cindolo

  105. HOX gene network is involved in the transcriptional regulation of in vivo human adipogenesis

    Article • Journal of Cellular Physiology, February 2003, Wiley

    Dr alfredo procino, Luca Cindolo

  106. Nephron sparing surgery in localized renal cell carcinoma: impact on postoperative quality of life

    Article • European Urology Supplements, January 2002, Elsevier

    Luca Cindolo

  107. Galectin‐1 and galectin‐3 expression in human bladder transitional‐cell carcinomas

    Article • International Journal of Cancer, February 1999, Wiley

    Prof Raffaela Pero, Luca Cindolo

  108. Galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas

    Article • International Journal of Cancer, February 1999, Wiley

    Prof Raffaela Pero, Luca Cindolo